2 results
Approved WMOCompleted
The study objective is to assess the safety and efficacy of the Svelte Drug-Eluting Coronary Stent Integrated Delivery System (IDS) compared to the Resolute IntegrityTM Drug-Eluting Stent in patients with single, de novo coronary artery lesions.
Approved WMOPending
The primary objective of this clinical performance study is to evaluate the effectiveness of the B7-H4 (A57.1) CTA in identifying B7-H4 positive (B7-H4 membrane staining at any intensity in >=25% tumor cells) ovarian, endometrial, biliary…